Plant · Scientific monograph
Juniperus communis
Common juniper
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Traditional urinary use, Digestive research
Research overview
Historical use
EMA recognizes traditional use for specified juniper berry preparations in minor urinary complaints and digestive discomfort; berry and essential oil monographs are separate [1,2].
Modern research context
A short study evaluated a named juniper-oil product for functional dyspepsia. The abstract is available, but the full report was not independently reviewed, so this profile makes no efficacy or safety conclusion [3].
Adverse effects
EMA describes preparation-specific cautions [1,2]. The trial abstract was identified but its full report was not independently reviewed; product-specific safety conclusions are therefore not drawn.
Contraindications
EMA advises against use in conditions requiring fluid restriction and does not establish medicinal use in pregnancy, lactation or people under 18 [1]. Do not transfer oil trial results to berries [3].
Clinical and phytochemical data
Used part
Pseudo-fruit (berry) for traditional-use scope; essential oil is a separate preparation [1-3].
Primary active compounds
Volatile oil constituents are preparation-dependent; EMA distinguishes berry and essential-oil materials [1,2].
Mechanism of action
The short dyspepsia trial does not establish mechanism for juniper berries or other preparations [3].
Pharmacokinetics
Absorption
Human PK data for juniper berry medicines were not identified; the short oil trial does not establish a general PK profile [1-3].
Distribution
Not characterized.
Metabolism
Not characterized.
Excretion
Traditional-use diuretic context is not a human PK study; general excretion data remain insufficient [1].
Safety and interactions
Drug interactions
No broad clinical interaction profile established; EMA notes caution with diuretic co-use for relevant preparations [1,2].
Toxicity
Long-term safety data are limited; EMA assessment notes sparse clinical safety data [1,2].
Special precautions
Pregnancy
Pregnancy safety is not established; EMA advises against medicinal use in pregnancy [1].
Lactation
Lactation safety is not established; EMA advises against medicinal use in lactation [1].
Hepatic impairment
No hepatic impairment-specific evidence identified.
Renal impairment
No impairment-specific human evidence identified. EMA advises against use in fluid-restriction states for the pseudo-fruit monograph; this does not establish a general renal-disease contraindication [1].
Sources and references
- [1] EMA/HMPC. European Union herbal monograph on Juniperus communis L., galbulus (pseudo-fructus), revision 1. EMA/HMPC/241320/2021. https://www.ema.europa.eu/en/medicines/herbal/juniperi-galbulus-pseudo-fructus
- [2] EMA/HMPC. European Union herbal monograph on Juniperus communis L., aetheroleum. EMA herbal-product page: https://www.ema.europa.eu/en/medicines/herbal/juniperi-aetheroleum
- [3] Uwe Albrecht et al. Efficacy and safety of Roleca® juniper 100 mg in the treatment of functional dyspepsia: A randomized, double-blind, placebo-controlled trial. Phytomedicine. 2025;149:157542. PMID: 41240546. DOI: 10.1016/j.phymed.2025.157542.